"Olanzapine for Prevention of Chemotherapy Induced Nausea and Vomiting in Children and Adolescents Receiving Highly Emetogenic Chemotherapy (HEC)"
Clinical trial NCT03219710 · COMPLETED
Trial details
- NCT number
- NCT03219710
- Sponsor
- All India Institute of Medical Sciences
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-01
- Primary completion
- 2019-07-31
- Enrollment
- 240
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.